Percutaneous intervention in peripheral artery disease improves calf muscle phosphocreatine recovery kinetics: A pilot study

Amy M. West, Justin D. Anderson, Frederick H. Epstein, Craig H. Meyer, Klaus D. Hagspiel, Stuart S. Berr, Nancy L. Harthun, Arthur L. Weltman, Brian H. Annex, Christopher M. Kramer

Research output: Contribution to journalArticle

Abstract

We hypothesized that percutaneous intervention in the affected lower extremity artery would improve calf muscle perfusion and cellular metabolism in patients with claudication and peripheral artery disease (PAD) as measured by magnetic resonance imaging (MRI) and spectroscopy (MRS). Ten patients with symptomatic PAD (mean ± SD: age 57 ± 9 years; ankle-brachial index (ABI) 0.62 ± 0.17; seven males) were studied 2 months before and 10 months after lower extremity percutaneous intervention. Calf muscle phosphocreatine recovery time constant (PCr) in the revascularized leg was measured by 31P MRS immediately after symptom-limited exercise on a 1.5-T scanner. Calf muscle perfusion was measured using first-pass gadolinium-enhanced MRI at peak exercise. A 6-minute walk and treadmill test were performed. The PCr recovery time constant improved significantly following intervention (91 ± 33 s to 52 ± 34 s, p < 0.003). Rest ABI also improved (0.62 ± 0.17 to 0.93 ± 0.25, p < 0.003). There was no difference in MRI-measured tissue perfusion or exercise parameters, although the study was underpowered for these endpoints. In conclusion, in this pilot study, successful large vessel percutaneous intervention in patients with symptomatic claudication, results in improved ABI and calf muscle phosphocreatine recovery kinetics.

Original languageEnglish (US)
Pages (from-to)3-9
Number of pages7
JournalVascular Medicine
Volume17
Issue number1
DOIs
StatePublished - Feb 1 2012

Fingerprint

Phosphocreatine
Peripheral Arterial Disease
Ankle Brachial Index
Muscles
Perfusion
Magnetic Resonance Imaging
Exercise
Lower Extremity
Gadolinium
Exercise Test
Spectrum Analysis
Leg
Magnetic Resonance Spectroscopy
Arteries

Keywords

  • calf muscle
  • cardiovascular magnetic resonance
  • lower extremity percutaneous revascularization
  • perfusion
  • peripheral artery disease
  • phosphocreatine recovery

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

West, A. M., Anderson, J. D., Epstein, F. H., Meyer, C. H., Hagspiel, K. D., Berr, S. S., ... Kramer, C. M. (2012). Percutaneous intervention in peripheral artery disease improves calf muscle phosphocreatine recovery kinetics: A pilot study. Vascular Medicine, 17(1), 3-9. https://doi.org/10.1177/1358863X11431837

Percutaneous intervention in peripheral artery disease improves calf muscle phosphocreatine recovery kinetics : A pilot study. / West, Amy M.; Anderson, Justin D.; Epstein, Frederick H.; Meyer, Craig H.; Hagspiel, Klaus D.; Berr, Stuart S.; Harthun, Nancy L.; Weltman, Arthur L.; Annex, Brian H.; Kramer, Christopher M.

In: Vascular Medicine, Vol. 17, No. 1, 01.02.2012, p. 3-9.

Research output: Contribution to journalArticle

West, AM, Anderson, JD, Epstein, FH, Meyer, CH, Hagspiel, KD, Berr, SS, Harthun, NL, Weltman, AL, Annex, BH & Kramer, CM 2012, 'Percutaneous intervention in peripheral artery disease improves calf muscle phosphocreatine recovery kinetics: A pilot study', Vascular Medicine, vol. 17, no. 1, pp. 3-9. https://doi.org/10.1177/1358863X11431837
West, Amy M. ; Anderson, Justin D. ; Epstein, Frederick H. ; Meyer, Craig H. ; Hagspiel, Klaus D. ; Berr, Stuart S. ; Harthun, Nancy L. ; Weltman, Arthur L. ; Annex, Brian H. ; Kramer, Christopher M. / Percutaneous intervention in peripheral artery disease improves calf muscle phosphocreatine recovery kinetics : A pilot study. In: Vascular Medicine. 2012 ; Vol. 17, No. 1. pp. 3-9.
@article{0390aeb0b79f4b028fdc94d7765534f8,
title = "Percutaneous intervention in peripheral artery disease improves calf muscle phosphocreatine recovery kinetics: A pilot study",
abstract = "We hypothesized that percutaneous intervention in the affected lower extremity artery would improve calf muscle perfusion and cellular metabolism in patients with claudication and peripheral artery disease (PAD) as measured by magnetic resonance imaging (MRI) and spectroscopy (MRS). Ten patients with symptomatic PAD (mean ± SD: age 57 ± 9 years; ankle-brachial index (ABI) 0.62 ± 0.17; seven males) were studied 2 months before and 10 months after lower extremity percutaneous intervention. Calf muscle phosphocreatine recovery time constant (PCr) in the revascularized leg was measured by 31P MRS immediately after symptom-limited exercise on a 1.5-T scanner. Calf muscle perfusion was measured using first-pass gadolinium-enhanced MRI at peak exercise. A 6-minute walk and treadmill test were performed. The PCr recovery time constant improved significantly following intervention (91 ± 33 s to 52 ± 34 s, p < 0.003). Rest ABI also improved (0.62 ± 0.17 to 0.93 ± 0.25, p < 0.003). There was no difference in MRI-measured tissue perfusion or exercise parameters, although the study was underpowered for these endpoints. In conclusion, in this pilot study, successful large vessel percutaneous intervention in patients with symptomatic claudication, results in improved ABI and calf muscle phosphocreatine recovery kinetics.",
keywords = "calf muscle, cardiovascular magnetic resonance, lower extremity percutaneous revascularization, perfusion, peripheral artery disease, phosphocreatine recovery",
author = "West, {Amy M.} and Anderson, {Justin D.} and Epstein, {Frederick H.} and Meyer, {Craig H.} and Hagspiel, {Klaus D.} and Berr, {Stuart S.} and Harthun, {Nancy L.} and Weltman, {Arthur L.} and Annex, {Brian H.} and Kramer, {Christopher M.}",
year = "2012",
month = "2",
day = "1",
doi = "10.1177/1358863X11431837",
language = "English (US)",
volume = "17",
pages = "3--9",
journal = "Vascular Medicine (United Kingdom)",
issn = "1358-863X",
publisher = "SAGE Publications Ltd",
number = "1",

}

TY - JOUR

T1 - Percutaneous intervention in peripheral artery disease improves calf muscle phosphocreatine recovery kinetics

T2 - A pilot study

AU - West, Amy M.

AU - Anderson, Justin D.

AU - Epstein, Frederick H.

AU - Meyer, Craig H.

AU - Hagspiel, Klaus D.

AU - Berr, Stuart S.

AU - Harthun, Nancy L.

AU - Weltman, Arthur L.

AU - Annex, Brian H.

AU - Kramer, Christopher M.

PY - 2012/2/1

Y1 - 2012/2/1

N2 - We hypothesized that percutaneous intervention in the affected lower extremity artery would improve calf muscle perfusion and cellular metabolism in patients with claudication and peripheral artery disease (PAD) as measured by magnetic resonance imaging (MRI) and spectroscopy (MRS). Ten patients with symptomatic PAD (mean ± SD: age 57 ± 9 years; ankle-brachial index (ABI) 0.62 ± 0.17; seven males) were studied 2 months before and 10 months after lower extremity percutaneous intervention. Calf muscle phosphocreatine recovery time constant (PCr) in the revascularized leg was measured by 31P MRS immediately after symptom-limited exercise on a 1.5-T scanner. Calf muscle perfusion was measured using first-pass gadolinium-enhanced MRI at peak exercise. A 6-minute walk and treadmill test were performed. The PCr recovery time constant improved significantly following intervention (91 ± 33 s to 52 ± 34 s, p < 0.003). Rest ABI also improved (0.62 ± 0.17 to 0.93 ± 0.25, p < 0.003). There was no difference in MRI-measured tissue perfusion or exercise parameters, although the study was underpowered for these endpoints. In conclusion, in this pilot study, successful large vessel percutaneous intervention in patients with symptomatic claudication, results in improved ABI and calf muscle phosphocreatine recovery kinetics.

AB - We hypothesized that percutaneous intervention in the affected lower extremity artery would improve calf muscle perfusion and cellular metabolism in patients with claudication and peripheral artery disease (PAD) as measured by magnetic resonance imaging (MRI) and spectroscopy (MRS). Ten patients with symptomatic PAD (mean ± SD: age 57 ± 9 years; ankle-brachial index (ABI) 0.62 ± 0.17; seven males) were studied 2 months before and 10 months after lower extremity percutaneous intervention. Calf muscle phosphocreatine recovery time constant (PCr) in the revascularized leg was measured by 31P MRS immediately after symptom-limited exercise on a 1.5-T scanner. Calf muscle perfusion was measured using first-pass gadolinium-enhanced MRI at peak exercise. A 6-minute walk and treadmill test were performed. The PCr recovery time constant improved significantly following intervention (91 ± 33 s to 52 ± 34 s, p < 0.003). Rest ABI also improved (0.62 ± 0.17 to 0.93 ± 0.25, p < 0.003). There was no difference in MRI-measured tissue perfusion or exercise parameters, although the study was underpowered for these endpoints. In conclusion, in this pilot study, successful large vessel percutaneous intervention in patients with symptomatic claudication, results in improved ABI and calf muscle phosphocreatine recovery kinetics.

KW - calf muscle

KW - cardiovascular magnetic resonance

KW - lower extremity percutaneous revascularization

KW - perfusion

KW - peripheral artery disease

KW - phosphocreatine recovery

UR - http://www.scopus.com/inward/record.url?scp=84863229858&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863229858&partnerID=8YFLogxK

U2 - 10.1177/1358863X11431837

DO - 10.1177/1358863X11431837

M3 - Article

C2 - 22363013

AN - SCOPUS:84863229858

VL - 17

SP - 3

EP - 9

JO - Vascular Medicine (United Kingdom)

JF - Vascular Medicine (United Kingdom)

SN - 1358-863X

IS - 1

ER -